Navigation Links
ChromaDex® Names Debra Heim as COO
Date:2/21/2012

IRVINE, Calif., Feb. 21, 2012 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries and marketer of BluScience™ (http://www.bluscience.com), its recently launched line of dietary supplements, announced today the Board has appointed Debra A. Heim as the company's Chief Operating Officer and President of its Consumer Products Division.

(Logo:  http://photos.prnewswire.com/prnh/20110830/LA59283LOGO)

Debra Heim, age 43, has over 20 years of experience with consumer brands companies. Prior to joining ChromaDex, Ms. Heim spent 16 years with The Himmel Group (www.himmelgroup.com) where she served as its President and Chief Operating Officer since 2010. Previously, she served as the company's Chief Financial Officer for 12 years. During her tenure with The Himmel Group, Ms. Heim was part of the executive management team overseeing sales and marketing of the GOLD BOND MEDICATED POWDER and OVALTINE® businesses. Additionally, Debra built and managed the organization responsible for the manufacturing, sales order processing, distribution, accounting and finance, information technology systems, human resources and consumer services of the company.

Commenting on the announcement, ChromaDex's CEO Jeffrey Himmel stated, "Having personally worked with Debra for more than 15 years, I am thrilled to have her join the executive management team at ChromaDex. Her experience and skill sets with branded consumer products are an ideal fit, as we are just beginning the national retail launch of our

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. ChromaDex® Expands National Launch of its BluScience™ Line of Dietary Supplements Through McKesson
2. ChromaDex® Announces Management Changes
3. Entomological Society of America names 2008 award winners
4. American Library Association names NJIT prof’s Whale Music book a top ten
5. WCC Smart Search and Match Names Rudie Lion - Product Marketing Manager
6. WCC Smart Search and Match Names Rudie Lion - Product Marketing Manager
7. WCC Smart Search & Match Names Tarvinder Sembhi as VP Sales for the ID Market
8. Names turn preschoolers into vegetable lovers
9. AIBS names 2009 emerging public policy leaders
10. UC Riverside researcher names lichen after President Barack Obama
11. Impact Factor names Cell top research journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
(Date:8/5/2015)... New York , August 5, 2015 ... market report titled "Facial Recognition Market - Global Industry ... 2022", the global market for facial recognition is forecast ... is driven by increased demand for surveillance systems by ... the rising number of crimes and terrorist activities across ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... 12-week treatment of the fermented soy germ-based nutritional supplement ... and improved vascular stiffness, all factors that occur as ... study reported in a poster at the Women,s Health ... the first to provide evidence that a daily supplement ...
... of Cincinnati undergraduate student and two team members, there,s a ... in continuously recording the habits of snakes. This small-scale ... on snakes, since the LAT devices were originally developed for ... to measure temperature and pressure measuring pressure translates into ...
... -- Research from a Kansas State University professor may ... or to study neurological disorders. Mark Weiss, professor ... spinal cord injury or diseases such as Parkinson,s disease. ... and regenerative medicine -- a type of research that ...
Cached Biology News:Soy-based S-equol supplement reduces metabolic syndrome risk factors 2Soy-based S-equol supplement reduces metabolic syndrome risk factors 3UC research: Tracking Lake Erie water snake in fight against invasive fish 2UC research: Tracking Lake Erie water snake in fight against invasive fish 3Genetic research develops tools for studying diseases, improving regenerative treatment 2
(Date:8/28/2015)... ... 28, 2015 , ... Riordan-McKenna Institute founders, stem ... that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic ... surgical knee wound. , The case involved a 78-year-old male, who presented with ...
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage Biotech ... PBT.U), and Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... Phase I study of BHV-0223, a glutamate modulating ... regarding BHV-0223 and recently obtained clearance from the ... with human testing. Portage holds 54% equity interest ...
(Date:8/27/2015)... YORK , August 27, 2015 ... enhancing image processing functions in the human vision system, announced ... point guard Chris Paul to develop ... players who want to improve their real-life on-court performance. ... the court, whether it is shooting a ball or blocking ...
(Date:8/26/2015)... KS (PRWEB) , ... August 26, 2015 , ... ... Biologic Solutions, announces today that a second US laboratory is to open in ... accordance with the continued partnership and long-term growth of research and development through ...
Breaking Biology Technology:Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3
... ... Applications, ST. LOUIS and ... Sangamo BioSciences, Inc.,(Nasdaq: SGMO ) today announced a research and ... the use of its,proprietary zinc finger nuclease (ZFN) technology to develop ...
... require a transparent conductive layer with a high work ... an organic layer to produce more light. , ... on Science and Technology of Synthetic Metals in Brazil ... A balanced injection of positive and negative charge carriers ...
... SAN MARINO, Calif., July 8 Epeius Biotechnologies,Corporation ... Drug,Designation by the U.S. Food and Drug Administration ... criteria, including the rarity,seriousness, and current lack of ... scientific and medicinal merit of Rexin-G, the,granting of ...
Cached Biology Technology:Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 2Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 3Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 4Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals 5Research helps understand factors that influence efficiency of organic-based devices 2Research helps understand factors that influence efficiency of organic-based devices 3Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma 2